Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Magali, Matsumiya"'
Autor:
Eileen McNeill, Elena Stylianou, Mark J. Crabtree, Rachel Harrington-Kandt, Anna-Lena Kolb, Marina Diotallevi, Ashley B. Hale, Paulo Bettencourt, Rachel Tanner, Matthew K. O’Shea, Magali Matsumiya, Helen Lockstone, Julius Müller, Helen A. Fletcher, David R. Greaves, Helen McShane, Keith M. Channon
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-16 (2018)
Inducible nitric oxide (NO) synthase (iNOS) is essential in the response to mycobacterial infection, yet NOS signalling can occur through NO-dependent or NO-independent pathways. Here the authors show macrophage Gch1 and tetrahydrobiopterin mediate N
Externí odkaz:
https://doaj.org/article/6b10bf22d1cf44e59fc4465f802a33e8
Autor:
Rachel Tanner, Iman Satti, Stephanie A. Harris, Matthew K. O'Shea, Deniz Cizmeci, Daniel O'Connor, Agnieszka Chomka, Magali Matsumiya, Rachel Wittenberg, Angela M. Minassian, Joel Meyer, Helen A. Fletcher, Helen McShane
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Tuberculosis (TB) remains a leading global cause of morbidity and mortality and an effective new vaccine is urgently needed. A major barrier to the rational development of novel TB vaccines is the lack of a validated immune correlate or biomarker of
Externí odkaz:
https://doaj.org/article/3a79f6ae1f1441c1bc01dc2dd53f6d80
Autor:
Matthew K. O'Shea, Thomas E. Fletcher, Julius Muller, Rachel Tanner, Magali Matsumiya, J. Wendi Bailey, Jayne Jones, Steven G. Smith, Gavin Koh, William G. Horsnell, Nicholas J. Beeching, James Dunbar, Duncan Wilson, Adam F. Cunningham, Helen McShane
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Soil-transmitted helminths and Mycobacterium tuberculosis frequently coincide geographically and it is hypothesized that gastrointestinal helminth infection may exacerbate tuberculosis (TB) disease by suppression of Th1 and Th17 responses. However, f
Externí odkaz:
https://doaj.org/article/5527e25defdb4f11832015b820d593b6
Autor:
Helen A. Fletcher, Margaret A. Snowden, Bernard Landry, Wasima Rida, Iman Satti, Stephanie A. Harris, Magali Matsumiya, Rachel Tanner, Matthew K. O’Shea, Veerabadran Dheenadhayalan, Leah Bogardus, Lisa Stockdale, Leanne Marsay, Agnieszka Chomka, Rachel Harrington-Kandt, Zita-Rose Manjaly-Thomas, Vivek Naranbhai, Elena Stylianou, Fatoumatta Darboe, Adam Penn-Nicholson, Elisa Nemes, Mark Hatherill, Gregory Hussey, Hassan Mahomed, Michele Tameris, J Bruce McClain, Thomas G. Evans, Willem A. Hanekom, Thomas J. Scriba, Helen McShane
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-11 (2016)
BCG vaccine confers only partial protection against tuberculosis. Here the authors show that the risk of tuberculosis infection and progression to disease in BCG-immunized children positively correlates with the frequency of activated HLA-DR+CD4+T ce
Externí odkaz:
https://doaj.org/article/edab3b0f77064ee189c1a3294bd52daa
Autor:
Magali Matsumiya, Elena Stylianou, Kristin Griffiths, Zoe Lang, Joel Meyer, Stephanie A Harris, Rosalind Rowland, Angela M Minassian, Ansar A Pathan, Helen Fletcher, Helen McShane
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e67922 (2013)
A better understanding of the relationships between vaccine, immunogenicity and protection from disease would greatly facilitate vaccine development. Modified vaccinia virus Ankara expressing antigen 85A (MVA85A) is a novel tuberculosis vaccine candi
Externí odkaz:
https://doaj.org/article/58cafdfb650f4af69c100d33f85ac92f
Autor:
Helen A. Fletcher, Margaret A. Snowden, Bernard Landry, Wasima Rida, Iman Satti, Stephanie A. Harris, Magali Matsumiya, Rachel Tanner, Matthew K. O’Shea, Veerabadran Dheenadhayalan, Leah Bogardus, Lisa Stockdale, Leanne Marsay, Agnieszka Chomka, Rachel Harrington-Kandt, Zita-Rose Manjaly-Thomas, Vivek Naranbhai, Elena Stylianou, Fatoumatta Darboe, Adam Penn-Nicholson, Elisa Nemes, Mark Hatherill, Gregory Hussey, Hassan Mahomed, Michele Tameris, J. Bruce McClain, Thomas G. Evans, Willem A. Hanekom, Thomas J. Scriba, Helen McShane
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-1 (2016)
Nature Communications 7, Article number: 11290 (2016); Published: 12 April 2016; Updated: 6 May 2016. The original version of this Article contained an error in the spelling of the author Mark Hatherill, which was incorrectly given as Mark Hatheril.
Externí odkaz:
https://doaj.org/article/b95da97828c544a898fe07abb1e26945
Autor:
Rachel, Tanner, Iman, Satti, Stephanie A, Harris, Matthew K, O'Shea, Deniz, Cizmeci, Daniel, O'Connor, Agnieszka, Chomka, Magali, Matsumiya, Rachel, Wittenberg, Angela M, Minassian, Joel, Meyer, Helen A, Fletcher, Helen, McShane
Publikováno v:
Frontiers in Immunology
Tuberculosis (TB) remains a leading global cause of morbidity and mortality and an effective new vaccine is urgently needed. A major barrier to the rational development of novel TB vaccines is the lack of a validated immune correlate or biomarker of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::096bd227aa0b2adb9999e5c8c997c8be
https://pubmed.ncbi.nlm.nih.gov/31998295
https://pubmed.ncbi.nlm.nih.gov/31998295
Autor:
Helen McShane, Bernard Landry, Matthew K. O'Shea, Thomas J. Scriba, Elena Stylianou, Gregory D Hussey, Julius Muller, Willem A. Hanekom, Stephanie A. Harris, Zita-Rose Manjaly Thomas, Hassan Mahomed, Lisa Stockdale, Iman Satti, Margaret A Snowden, Magali Matsumiya, Stanley Kimbung Mbandi, Leanne Marsay, J. Bruce McClain, Michele Tameris, Mark Hatherill, Rachel Tanner, Thomas G. Evans, Rachel Harrington-Kandt, Agnieszka Chomka, Helen A. Fletcher, Vivek Naranbhai
Publikováno v:
JCI Insight
Immune activation is associated with increased risk of tuberculosis (TB) disease in infants. We performed a case-control analysis to identify drivers of immune activation and disease risk. Among 49 infants who developed TB disease over the first 2 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bbe2813fb511aa56af27ef21be0ebb
https://pubmed.ncbi.nlm.nih.gov/31697647
https://pubmed.ncbi.nlm.nih.gov/31697647
Autor:
Stephanie A. Harris, Andrew White, Helen McShane, Hal Drakesmith, Rachel Harrington-Kandt, Eneida A. Parizotto, Helen A. Fletcher, Elena Stylianou, Julius Muller, Vivek Naranbhai, Matthew K. O'Shea, Rachel Tanner, Sally Sharpe, Paulo Bettencourt, Mike Dennis, Magali Matsumiya
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-2 (2019)
Scientific Reports
Scientific Reports
The current vaccine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. There has been a recent resur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32febdfda1561ecdf488bc51cf8f9b73
https://doi.org/10.1038/s41598-019-41387-8
https://doi.org/10.1038/s41598-019-41387-8
Autor:
Julius Muller, Rachel Tanner, Magali Matsumiya, Margaret A. Snowden, Bernard Landry, Iman Satti, Stephanie A. Harris, Matthew K. O’Shea, Lisa Stockdale, Leanne Marsay, Agnieszka Chomka, Rachel Harrington-Kandt, Zita-Rose Manjaly Thomas, Vivek Naranbhai, Elena Stylianou, Stanley Kimbung Mbandi, Mark Hatherill, Gregory Hussey, Hassan Mahomed, Michele Tameris, J. Bruce McClain, Thomas G. Evans, Willem A. Hanekom, Thomas J. Scriba, Helen McShane, Helen A. Fletcher
Immune activation is associated with increased risk of tuberculosis (TB) disease in infants. We performed a case-control analysis to identify drivers of immune activation and disease risk. Among 49 infants who developed TB disease over the first two
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bab979e8ce32010c1639197f3a1c59d
